Skip to main content

Thrombogenics DRC - A Phase 1, open-label, multicenter, dose escalation study to evaluate the safety and tolerability of a single intravitreal injection of THR-149 for the treatment of diabetic macular edema (DME)

Research Grant
Duke Scholars

Administered By

Ophthalmology

Awarded By

ThromboGenics Inc

Start Date

March 27, 2018

End Date

March 17, 2021
 

Administered By

Ophthalmology

Awarded By

ThromboGenics Inc

Start Date

March 27, 2018

End Date

March 17, 2021